Annual Total Assets
$135.57 M
-$18.82 M-12.19%
September 30, 2024
Summary
- As of February 7, 2025, AVXL annual total assets is $135.57 million, with the most recent change of -$18.82 million (-12.19%) on September 30, 2024.
- During the last 3 years, AVXL annual total assets has fallen by -$26.05 million (-16.12%).
- AVXL annual total assets is now -16.12% below its all-time high of $161.62 million, reached on September 30, 2021.
Performance
AVXL Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$135.57 M
-$5.97 M-4.22%
September 30, 2024
Summary
- As of February 7, 2025, AVXL quarterly total assets is $135.57 million, with the most recent change of -$5.97 million (-4.22%) on September 30, 2024.
- Over the past year, AVXL quarterly total assets has dropped by -$5.97 million (-4.22%).
- AVXL quarterly total assets is now -18.54% below its all-time high of $166.42 million, reached on June 30, 2021.
Performance
AVXL Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
AVXL Total Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -12.2% | -4.2% |
3 y3 years | -16.1% | -16.1% |
5 y5 years | +435.2% | -16.1% |
AVXL Total Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -16.1% | at low | -15.4% | at low |
5 y | 5-year | -16.1% | +435.2% | -18.5% | +337.0% |
alltime | all time | -16.1% | -100.0% | -18.5% | -100.0% |
Anavex Life Sciences Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | $135.57 M(-12.2%) | $135.57 M(-4.2%) |
Jun 2024 | - | $141.53 M(-2.1%) |
Mar 2024 | - | $144.52 M(-2.4%) |
Dec 2023 | - | $148.07 M(-4.1%) |
Sep 2023 | $154.39 M(+1.1%) | $154.39 M(-2.2%) |
Jun 2023 | - | $157.81 M(-0.9%) |
Mar 2023 | - | $159.19 M(+7.3%) |
Dec 2022 | - | $148.37 M(-2.8%) |
Sep 2022 | $152.71 M(-5.5%) | $152.71 M(-4.7%) |
Jun 2022 | - | $160.22 M(-0.0%) |
Mar 2022 | - | $160.28 M(+2.2%) |
Dec 2021 | - | $156.90 M(-2.9%) |
Sep 2021 | $161.62 M(+367.9%) | $161.62 M(-2.9%) |
Jun 2021 | - | $166.42 M(+99.1%) |
Mar 2021 | - | $83.57 M(+53.8%) |
Dec 2020 | - | $54.33 M(+57.3%) |
Sep 2020 | $34.54 M(+36.4%) | $34.54 M(+9.2%) |
Jun 2020 | - | $31.63 M(+2.0%) |
Mar 2020 | - | $31.02 M(-1.3%) |
Dec 2019 | - | $31.42 M(+24.1%) |
Sep 2019 | $25.33 M(-3.3%) | $25.33 M(+15.3%) |
Jun 2019 | - | $21.97 M(+6.9%) |
Mar 2019 | - | $20.55 M(-7.0%) |
Dec 2018 | - | $22.10 M(-15.7%) |
Sep 2018 | $26.21 M(-5.9%) | $26.21 M(-2.2%) |
Jun 2018 | - | $26.79 M(+3.5%) |
Mar 2018 | - | $25.90 M(-8.6%) |
Dec 2017 | - | $28.34 M(+1.8%) |
Sep 2017 | $27.84 M(+193.1%) | $27.84 M(+11.8%) |
Jun 2017 | - | $24.91 M(+5.5%) |
Mar 2017 | - | $23.61 M(+10.4%) |
Dec 2016 | - | $21.37 M(+125.0%) |
Sep 2016 | $9.50 M(-38.6%) | $9.50 M(-3.5%) |
Jun 2016 | - | $9.84 M(-18.7%) |
Mar 2016 | - | $12.12 M(-13.6%) |
Dec 2015 | - | $14.02 M(-9.3%) |
Sep 2015 | $15.47 M | $15.47 M(+93.9%) |
Jun 2015 | - | $7.98 M(+25.4%) |
Mar 2015 | - | $6.36 M(-9.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | - | $7.05 M(-4.1%) |
Sep 2014 | $7.35 M(+1769.2%) | $7.35 M(-21.0%) |
Jun 2014 | - | $9.31 M(-9.5%) |
Mar 2014 | - | $10.29 M(+6720.7%) |
Dec 2013 | - | $150.90 K(-61.6%) |
Sep 2013 | $393.40 K(+2880.3%) | $393.40 K(>+9900.0%) |
Jun 2013 | - | $3500.00(+600.0%) |
Mar 2013 | - | $500.00(-99.4%) |
Dec 2012 | - | $79.90 K(+505.3%) |
Sep 2012 | $13.20 K(-93.5%) | $13.20 K(-40.3%) |
Jun 2012 | - | $22.10 K(-88.4%) |
Mar 2012 | - | $191.10 K(+125.9%) |
Dec 2011 | - | $84.60 K(-58.3%) |
Sep 2011 | $203.00 K(-38.4%) | $203.00 K(-84.1%) |
Jun 2011 | - | $1.28 M(+1874.1%) |
Mar 2011 | - | $64.80 K(-86.8%) |
Dec 2010 | - | $489.30 K(+48.4%) |
Sep 2010 | $329.80 K(-19.3%) | $329.80 K(-79.0%) |
Jun 2010 | - | $1.57 M(+585.9%) |
Mar 2010 | - | $229.10 K(+215.1%) |
Dec 2009 | - | $72.70 K(-82.2%) |
Sep 2009 | $408.60 K(+5575.0%) | $408.60 K(-48.9%) |
Jun 2009 | - | $799.00 K(+906.3%) |
Mar 2009 | - | $79.40 K(+5571.4%) |
Dec 2008 | - | $1400.00(-80.6%) |
Sep 2008 | $7200.00(>+9900.0%) | $7200.00(-93.6%) |
Jun 2008 | - | $111.70 K(+20.2%) |
Mar 2008 | - | $92.90 K(-28.9%) |
Dec 2007 | - | $130.60 K(>+9900.0%) |
Sep 2007 | $0.00(-100.0%) | $0.00(-100.0%) |
Jun 2007 | - | $100.00(-99.3%) |
Mar 2007 | - | $15.00 K(+233.3%) |
Dec 2006 | - | $4500.00(-64.0%) |
Sep 2006 | $12.50 K(+1150.0%) | $12.50 K(-37.2%) |
Jun 2006 | - | $19.90 K(>+9900.0%) |
Mar 2006 | - | $100.00(0.0%) |
Dec 2005 | - | $100.00(-90.0%) |
Sep 2005 | $1000.00(-96.4%) | $1000.00 |
Sep 2004 | $28.10 K | - |
FAQ
- What is Anavex Life Sciences annual total assets?
- What is the all time high annual total assets for Anavex Life Sciences?
- What is Anavex Life Sciences annual total assets year-on-year change?
- What is Anavex Life Sciences quarterly total assets?
- What is the all time high quarterly total assets for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly total assets year-on-year change?
What is Anavex Life Sciences annual total assets?
The current annual total assets of AVXL is $135.57 M
What is the all time high annual total assets for Anavex Life Sciences?
Anavex Life Sciences all-time high annual total assets is $161.62 M
What is Anavex Life Sciences annual total assets year-on-year change?
Over the past year, AVXL annual total assets has changed by -$18.82 M (-12.19%)
What is Anavex Life Sciences quarterly total assets?
The current quarterly total assets of AVXL is $135.57 M
What is the all time high quarterly total assets for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly total assets is $166.42 M
What is Anavex Life Sciences quarterly total assets year-on-year change?
Over the past year, AVXL quarterly total assets has changed by -$5.97 M (-4.22%)